Education around innovative testing for early detection of lung cancer and draft legislation to provide Medicare coverage of certain tests. Health insurance accessibility.
2026 · 3rd Quarter (July 1 - Sep 30)
DELFI DIAGNOSTICS
Filed by TODD STRATEGY GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- TODD STRATEGY GROUP
- Client
- DELFI DIAGNOSTICS
- Filing UUID
- e8801721-3fe7-462c-b3a4-76a67a2f3987
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to intellectual property protection and market access. Drug pricing, coverage, value, access and quality. IRA Implementation. Transparency issues.
US Tariffs patient protection. Supply chain issues and shortages.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.